Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Immuron Limited ( (AU:IMC) ) has provided an update.
Immuron Limited has issued 1,801,680 ordinary shares without disclosure under specific provisions of the Corporations Act. The company complies with necessary legal requirements and confirms there is no undisclosed information relating to this issuance, which may impact its transparency and investor relations positively.
More about Immuron Limited
Immuron Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of oral immunotherapeutics for the treatment of gut-mediated diseases. The company targets markets in the healthcare sector, leveraging its proprietary technology platform.
YTD Price Performance: 12.50%
Average Trading Volume: 31,579
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €13.74M
Find detailed analytics on IMC stock on TipRanks’ Stock Analysis page.
